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Abstract 
Background: Due to the limited data available in the pediatric population and lack of interventional studies to show 
that administration of vitamin D indeed improves clinical outcomes, opinion is still divided as to whether it is just an 
innocent bystander or a marker of severe disease. Our objective was therefore to estimate the prevalence of vitamin 
D deficiency in children admitted to intensive care unit (ICU) and to examine its association with duration of ICU stay 
and other key clinical outcomes.
Methods: We prospectively enrolled children aged 1 month–17 years admitted to the ICU over a period of 8 months 
(n = 101). The primary objectives were to estimate the prevalence of vitamin D deficiency (serum 25 (OH) <20 ng/mL) 
at ‘admission’ and to examine its association with length of ICU stay.
Results: The prevalence of vitamin D deficiency was 74 % (95 % CI: 65–88). The median (IQR) duration of ICU stay was 
significantly longer in ‘vitamin D deficient’ children (7 days; 2–12) than in those with ‘no vitamin D deficiency’ (3 days; 
2–5; p = 0.006). On multivariable analysis, the association between length of ICU stay and vitamin D deficiency 
remained significant, even after adjusting for key baseline variables, diagnosis, illness severity (PIM-2), PELOD, and 
need for fluid boluses, ventilation, inotropes and mortality [adjusted mean difference (95 % CI): 3.5 days (0.50–6.53); 
p = 0.024].
Conclusions: We observed a high prevalence of vitamin D deficiency in critically ill children in our study population. 
Vitamin D deficient children had a longer duration of ICU stay as compared to others.
Keywords: Vitamin D deficiency, 25 (OH) D deficiency, Prevalence, Critically ill, Vitamin D, 25 (OH) D, Tropical country, 
Duration of PICU stay
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Background
Vitamin D deficiency is common and has been estimated 
to affect about one billion people worldwide [1]. While 
the primary role of this pleiotropic hormone is regulation 
of calcium metabolism, it also plays a key role in several 
pathways of the innate immune response system, con-
trolling cell growth, differentiation and apoptosis [1], [2]. 
About 90  % of vitamin D needs are met with adequate 
sun exposure while dietary sources contribute only to the 
remaining 10 % of daily requirement [1].
It is well known that any critical illness or injury dis-
turbs the internal milieu of the body and may affect 
the reserves of vital nutrients and minerals of the body. 
Nutrition is often suboptimal in these patients and this 
may further aggravate any deficiencies. Vitamin D defi-
ciency has been reported to be widely prevalent in criti-
cally ill children from ICUs worldwide [3–6]. According 
to these studies, the prevalence of vitamin D deficiency 
has ranged anywhere from 30 to 70  % [3–6]. Although 
one would expect that in the tropics with greater sun 
exposure, vitamin D deficiency would be less as com-
pared to that from the temperate regions of the world, 
the prevalence reported from the tropical countries 
is similar [6–10]. In one of the largest pediatric studies 
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published till date, the authors observed lower vitamin D 
levels in those over weight as compared to underweight 
children [4]. Whether this holds true in patients admit-
ted to resource poor settings where the burden of under-
nourished children is much higher is yet to be evaluated. 
Such data would be useful in designing clinical trials tar-
geting this important subgroup of critically ill children.
Whether vitamin D deficiency affects illness sever-
ity and clinical outcomes has been the subject of much 
debate in the pediatric as well as the adult population. 
While in few of these studies, it has been associated with 
greater illness severity at presentation, increased need for 
inotropes, mechanical ventilation, duration of stay and 
even mortality [3–6, 11, 12] in few others no such asso-
ciation was found [13, 14]. Due to the limited data avail-
able in the pediatric population and lack of interventional 
studies to show that administration of vitamin D indeed 
improves clinical outcomes, opinion is still divided as to 
whether it is just an innocent bystander or a marker of 
severe disease. Further evidence from the pediatric popu-
lation and interventional studies is therefore needed to 
address this dilemma.
With this background, we hypothesized that the preva-
lence of vitamin D deficiency would be high in critically 
ill children admitted to our ICU and that this deficiency 




We conducted this prospective observational study over 
a period of 8 months (July–Dec 2013) in children admit-
ted to the pediatric intensive care unit (PICU) of our ter-
tiary care centre.
Participants
All critically ill children aged ≤17  years (1  month–
≤17  years) admitted to PICU were enrolled till the 
estimated sample size was met. We excluded children 
who were already on vitamin D supplementation, had 
received large doses for rickets or documented vitamin 
D deficiency in the past 1  year or steroids for at least 
10 days before admission, or had recent kidney stones or 
chronic kidney disease. Eligible children were enrolled in 
the study after obtaining informed written consent from 
parents. The study was approved by the Institutional Eth-
ics Committee.
Objectives and outcome measures
Our primary objectives were to estimate (1) the preva-
lence of vitamin D deficiency, defined as serum 25 (OH) 
D ≤ 20 ng/mL [15] and (2) the association between vita-
min D deficiency and length of ICU stay. Our secondary 
objectives were to (1) evaluate the prevalence of vitamin 
D deficiency in moderately undernourished and severely 
undernourished children [16] and (2) examine the associ-
ation between vitamin D deficiency and other important 
variables such as Pediatric Logistic Organ Dysfunction 
(PELOD) score at 24 h, need for fluid boluses during first 
6 h, need for mechanical ventilation and inotropes, and 
mortality. The definitions used for the purpose of the 
study are provided in panel 1 (Additional file 1: Table S1).
Methods
The children were managed as per preexisting protocols 
for management for various conditions. We followed a 
uniform protocol of nutritional support for all children 
admitted in PICU [17] irrespective of their underlying 
nutritional status in the acute phase of their illness. Calo-
ries and proteins for growth were increased as per their 
recommended dietary allowance (RDA) once we could 
achieve full feeds in these children. And once we achieved 
full feeds, within a day or two they were shifted to the 
step down unit where their growth was monitored till 
their discharge. We did not use routine supplementation 
of vitamin D in any of the children. Data were recorded 
on a pre-specified data collection form which included 
demographic details, illness severity score (Pediatric 
index of mortality-2 or PIM-2) at admission, duration of 
sun exposure (determined by questioning the parents as 
to the number of hours the child stayed outdoors on an 
average per day) and clinical details on a daily basis till 
death or discharge from the hospital. Relevant laboratory 
tests were performed on all patients at admission. Arte-
rial lactate, ionized calcium, parathyroid hormone were 
measured at inclusion. Samples for estimation of serum 
25 (OH) D levels were drawn at admission (within the 
first hour) alongside other blood tests. Samples were cold 
centrifuged at 4 °C and the plasma aliquoted and stored 
at −20 °C till sufficient samples were collected to run the 
test. Serum 25-hydroxyvitamin D was measured with 
automated chemiluminescent immunoassay technology 
(VITROS eci, Johnson and Johnson Ortho Clinical Diag-
nostics). The analytical sensitivity of this test is 4 ng/mL 
for 25 (OH) D with a reportable range of 4–512 ng/mL.
Sample size estimation
We calculated the sample size for the first primary objec-
tive—prevalence of vitamin D deficiency. Assuming the 
prevalence of vitamin D deficiency to be 50  %, a confi-
dence level of 95 %, absolute precision of 10 %, and design 
effect of 1, the sample size required was 97.
Statistical analysis
Data were entered into Microsoft Excel 2007 and ana-
lyzed using Stata 11.2 (Stata Corp, College Station, TX). 
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Results are presented as mean (SD) or median (inter-
quartile range) as appropriate for continuous variables 
and as absolute numbers (%) for categorical variables. 
For determining association between vitamin D defi-
ciency and demographic and key clinical outcomes, we 
performed univariable analysis using Student’s t test/Wil-
coxon rank-sum test and chi-square test for continuous 
and categorical variables, respectively. As our primary 
objective was to study the association between vitamin D 
deficiency and length of stay, we performed multivariable 
regression analysis with length of stay as the dependant 
variable after adjusting for important baseline variables 
such as age, gender, PIM-2, PELOD, weight for age, diag-
nosis and, outcome variables like mechanical ventilation, 
inotropes, need for fluid boluses in first 6  h and mor-
tality. The selection of baseline variables was before the 
start of the study. We used clinically important variables 
irrespective of p values for the multivariable analysis. The 
results of the multivariable analysis are reported as mean 
difference with 95 % confidence intervals (CI).
Results
A total of 196 children were admitted to the ICU during 
the study period. Of these 95 were excluded as per pre-
specified exclusion criteria (Fig. 1) and inability to sam-
ple patients for 2 months (September and October) due 
to logistic reasons. Baseline demographic and clinical 
data are described in Table 1. The median age was 3 years 
(IQR 0.1–9) and there was a slight preponderance of boys 
(52 %). The median (IQR) PIM-2 probability of death (%) 
at admission was 12 (8–26) and PELOD score at 24 h was 
21 (20–22). About 40 % were admitted during the winter 
season (Nov–Dec). The most common admitting diagno-
sis was pneumonia (19 %) and septic shock (19 %). Fifteen 
children had features of hypocalcemia at admission.
The prevalence of vitamin D deficiency was 74 % (95 % 
CI: 65–88) (Table 2) with a median serum vitamin D level 
of 5.8  ng/mL (IQR: 4–8) in those deficient. Sixty one  % 
(n =  62) had severe deficiency (levels <15  ng/mL) [18]. 
The prevalence of vitamin D deficiency was 80 % (95 % 
CI: 66–93) in children with moderate under-nutrition 
while it was 70 % (95 % CI: 53–87) in those with severe 
under-nutrition (Table  2). The median (IQR) serum 25 
(OH) D values for moderately undernourished, severely 
undernourished, and in those without under-nutrition 
were 8.35  ng/mL (5.6, 18.7), 11.2  ng/mL (4.6, 28), and 
14 ng/mL (5.5, 22), respectively. There was no significant 
association between either the prevalence of vitamin D 
deficiency (p = 0.63) or vitamin D levels (p = 0.49) and 
the nutritional status.
On evaluating the association between vitamin D defi-
ciency and important demographic and clinical vari-
ables, children with vitamin D deficiency were found to 
be older (median age, 4 vs. 1 years), and were more likely 
to receive mechanical ventilation (57 vs. 39 %) and ino-
tropes (53 vs. 31 %) (Table 3). None of these associations 
were, however, statistically significant.
The median (IQR) duration of ICU stay was signifi-
cantly longer in vitamin D deficient children (7  days; 
2–12) than in those with no vitamin D deficiency (3 days; 
2–5; p  =  0.006) (Fig.  2). On multivariable analysis, the 
association between length of ICU stay and vitamin D 
deficiency remained significant, even after adjusting for 
key baseline variables, diagnosis, illness severity (PIM-
2), PELOD, and need for fluid boluses, ventilation, ino-
tropes, and mortality [adjusted mean difference (95  % 
CI): 3.5 days (0.50–6.53); p = 0.024] (Table 4).
Discussion
Our data suggests a high prevalence (74 %) of vitamin D 
deficiency in our study population. In two recently pub-
lished studies from India, the prevalence in critically ill 
children in general was found to be 40 % [6] and in chil-
dren with sepsis it was around 50 % [10]. Despite being 
from a tropical country, the incidence of vitamin D defi-
ciency in our study is as high as has been reported from 
temperate countries such as in the study by Madden et al. 
[3]. While Madden et al. attributed the high incidence in 
the critically ill population in their study to factors such 
as transcapillary leak, fluid administration, and organ 
dysfunction, the high incidence observed in ours could be 
attributed to the high incidence of underlying deficiency 
in the general population as such in addition to the fac-
tors described above in critically ill children. Various fac-
tors like duration and timing of sun exposure, amount of 
skin exposed, skin pigmentation, dietary and genetic fac-
tors [19, 20], have been implicated as possible reasons for 
the high incidence of vitamin D deficiency observed in 
the tropics. However, as most cases in the general popu-
lation are asymptomatic therefore, the deficiency may 
not be clinically relevant. The same cannot be said for 
the critically ill population where there are multiple other 
factors involved and the physician is only trying to opti-
mize various therapeutic options to decide what works 
best for the patient. Therefore, deficiency of any essential 
nutrient or element deserves careful consideration.
Though high prevalence of vitamin D deficiency in 
critically ill adults and children has been documented, 
the impact of such deficiency is not yet clear. Few stud-
ies have documented significant association of deficiency 
with poor outcomes such as longer duration of ICU 
stay [4, 21], increased inotropic requirement [5, 11] and 
higher admission illness severity scores [3, 4]. We chose 
length of ICU stay as a clinically important outcome 
for the primary objective as it was one of the key vari-
ables found to be significantly associated with vitamin 
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D deficiency in the largest prospective study of 326 chil-
dren published till date [4]. On multivariable regres-
sion analysis, a value of less than 50 nmol/L (20 ng/mL) 
was independently associated with a PICU stay of an 
additional 1.92 days (95 % CI: 0.2–3.7; p = 0.03) in this 
study [4]. In our study too, we observed that the length 
of ICU stay was longer in children with ‘vitamin D defi-
ciency’ with a mean difference in PICU stay of 3.5 days 
(95 % CI: 0.50–6.53; p = 0.024) as compared to those ‘not 
deficient’. The association remained significant even after 
adjusting for key baseline and clinical variables. In com-
parison to the study by Mc Nally et al., the overall dura-
tion of stay as well as the difference in length of stay was 
greater in our study between ‘deficient’ and ‘not deficient’ 
children despite having similar incidence rates as in their 
study. Differences in patient population such as medical 
or surgical patients, age, genetic heterogeneity, underly-
ing nutrition status and admitting diagnosis could be the 
possible reasons for the longer duration of stay as com-
pared to their study. For example, in the study by Mc 
Nally et  al., the study population was mostly surgical 
(70  % of patients) (cardiac or otherwise) whereas our 
population was only medical. Medical conditions have 
a long drawn course of illness unlike surgical patients in 
who the recovery is quicker and patients are shifted out 
of the ICU once their post-op period is uneventful and 
they are extubated [4]. The mean duration of mechani-
cal ventilation (intubation) was 3.5  days in their study 
compared to 9 days in our study in the deficient children. 
Even in the other group it was 2.6  days in their study 
compared to 8 days in our study. Deficient children were 
older as compared to those ‘not deficient’. This could have 
been due to lack of exposure to adequate sunlight dur-
ing school hours or very little exposure owing to mostly 
indoor activities in this age group apart from dietary fac-
tors. Moreover, there were large numbers of undernour-
ished children in our study population which may have 
contributed to longer diseases course and slower recov-
ery in these children and therefore prolonged the stay 
in both groups and in the deficient group much more. 
The undernourished children with vitamin D deficiency 
could have had other micronutrient/essential nutrient 
Fig. 1 Study flow chart
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Table 1 Baseline demographic and clinical characteristics of children enrolled in the study
IQR interquartile range, PELOD pediatric logistic organ dysfunction, PIM pediatric index of mortality, CI confidence interval, ICP intracranial pressure, SGOT serum 
glutamic oxaloacetic transaminase, SGPT serum glutamic-pyruvic transaminase
Variable n = 101
Age (median, IQR) 3 (1 months, 9 years)
 <1 year 25 (25)
 1–5 years 33 (33)
 6–10 years 26 (26)
 11–17 years 17 (17)
Male (n %) 52 (52)
PIM-2 score (median, IQR) 12 (8–26)
PELOD score at admission (median, IQR) 21 (20–22)
Weight (Kg), median (IQR) 12 (5–19)
Duration of sun exposure in hours/day (only exposed parts) (median, IQR) 2 (0.5–3.5)
Admission season (n %)
 Nov–Dec 38 (38)
 Rest of the year 63 (63)
Nutritional status (n  %)
 Normal 32 (31.7)
 Moderately undernourished (−2 to −3 SD) 39 (38.6)
 Severely undernourished (<−3 SD) 30 (29.7)
Admitting diagnosis, n (%)
 Severe sepsis/septic shock 19 (19)
 Pneumonia 19 (19)
 Meningitis 16 (16)
 Seizure disorder 12 (12)
 Cardiac illness 10 (10)
 Tuberculosis 3 (3)
 Malaria 3 (3)
 Hepatic failure 2 (2)
 Raised ICP 1 (1)
 Any other 16 (16)
Underlying illness (n %)
 Congenital heart disease 9 (9)
 Nephrotic syndrome 3 (3)
 Genetic/neurometabolic disorders 3 (3)
 Tubercular meningitis 1 (1)
 Others including autoimmune/immunodeficiency  disorders 4 (4)
Neurological illness 15 (15)
Symptomatic hypocalcemia at admission (n %) 15 (15)
Laboratory investigations [mean (SD) or median (IQR)]
 Total calcium (mg/dL) 8 (1)
 Phosphate (mg/dL) 3.3 (0.5)
 Ionized calcium (mmol/L) 0.65 (0.25)
 Alkaline phosphatase (IU/L) 159 (123–343)
 SGOT (U/L) 57 (34–191)
 SGPT (U/L) 39 (22–114)
 Albumin (g/dL) 2.9 (0.4)
 Creatinine (mg/dL) 0.6 (0.4–0.7)
 Hemoglobin (g/dL) 9.7 (2)
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deficiency which were not overtly manifesting but could 
have contributed to the illness severity and therefore 
the slow recovery. The admitting diagnoses were mostly 
infections in our study compared to cardiac and non-
cardiac surgical cases in their study. In a previous study 
from our Institute, we observed that the median duration 
of stay in children with infections with or without shock 
is 5–7  days [22]. Thus, although the duration is longer 
compared to the study by Mc Nally et al., the differences 
in the patient population, clinical course and outcomes in 
these two settings might be contributory.
Vitamin D deficiency is presumed to increase mor-
bidity and mortality by its pleiotropic effects on vari-
ous organ system functions and its effects on innate and 
adaptive immunity [2, 12, 23]. Although a cause and 
effect relationship has not been clearly established due 
Table 2 Prevalence of vitamin D deficiency at admission
a Weight for age <−2 SD










P value between  
(B), (C) and (D)
Prevalence








Vitamin D levels at admission 
in deficient children (median, 
IQR)
5.8 (4–8) 14 (5.5–22) 8.35 (5.6–18.7) 11.2 (4.6–27.7) 0.49
Table 3 Comparison of demographic and clinical variables between vitamin D deficient and ‘not deficient’ groups
Data presented as number (proportion), mean (SD), or median (IQR)
PELOD pediatric logistic organ dysfunction, PIM pediatric index of mortality, CI confidence interval, IQR interquartile range, PICU pediatric intensive care unit
*  Compared to no under-nutrition





Age (yrs) 4 (0.5–9) 1 (0.4–8) 0.12
Female gender 39 (53) 10 (37) 0.16
Weight for age
 Moderate under-nutrition 31 (80) 8 (31) 0.33*
 Severe under-nutrition 21 (70) 9 (34) 0.66*
PIM2-probability of death (%) (median, IQR) 12.5 (8.6–23.5) 11.5 (6.8–30) 0.45
PELOD score (median, IQR) 21 (11–22) 21 (10–21) 0.09
Diagnosis (infections) 47 (64) 16 (59) 0.69
Hypocalcemia
 Total 27 (36) 6 (37.5) 0.9
 Ionized 58 (77) 15 (94) 0.14
Serum calcium (median, IQR)
 Total (mg/dL) 8.5 (7.4–8.9) 8.7 (7.1–9.2) 0.30
 Ionized (mmol/L) 0.65 (0.4–0.8) 0.70 (0.63–0.9) 0.21
Parathyroid levels (pg/mL) 16 (1.4) 16.6 (5) 0.36
Need for fluid boluses in first 6 h 44 (59) 12 (38) 0.14
Need for mechanical ventilation (n %) 43 (57) 10 (39) 0.10
Duration of ventilation (days)
 Median (IQR) 6.5 (3.5–14) 7 (2–13) 0.55
Need for inotropes (n %) 40 (53) 8 (31) 0.06
 Inotrope score 1320 (960–7040) 2440 (1440–3120) 0.23
 Duration of inotrope therapy, days (median, IQR) 2 (2–4) 1.5 (1–2) 0.15
Duration of PICU stay 7 (2–12) 3 (2–5) 0.006
Mortality (n %) 23 (31) 8 (31) 1.0
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to the conflicting evidence available, it is presumed that 
deficiency of this hormone may contribute to triggering 
or aggravating the multi organ dysfunction that occurs 
in the critically ill and is responsible for the increased 
morbidity and mortality in this population [3, 4, 23]. 
Although the differences were not statistically significant 
on univariable analysis, we observed that children who 
were vitamin D deficient at admission were more likely to 
require mechanical ventilation, inotropes, fluid boluses, 
have higher organ dysfunction scores and have prolonged 
duration of mechanical ventilation. All these factors in 
combination might have contributed to the slow recovery 
in this group of children thereby prolonging the length of 
stay in these patients.
There is limited data available in pediatric literature 
on the effect of vitamin D deficiency on clinically impor-
tant outcomes and there is no evidence to support that 
outcomes may improve with supplementation. Supple-
mentation of vitamin D in cases of deficiency is there-
fore, only subjective and should be based on features of 
deficiency (such as due to hypocalcemic seizures, bowed 
legs, rickets on X-ray) [24] rather than only the serum 
levels. A large randomized control trial (VITdAL-ICU) 
[25] in critically ill adults involving vitamin D supple-
mentation showed no significant difference in length of 
ICU stay or other outcomes after supplementation with 
vitamin D3 against placebo group. Presently, there is no 
recommendation for routine supplementation in adults 
too in view of inconclusive evidence. Therefore, there is 
a need to generate further evidence on the role of supple-
mentation in children.
Twenty-five (OH) D being the stable storage form, esti-
mation of its levels in serum reflects the total body stores 
Fig. 2 Association between vitamin D deficiency and length of ICU stay
Table 4 Multivariable regression for  association between   
length of  stay and  vitamin D deficiency after  adjusting 
for key baseline and clinical variables
PELOD pediatric logistic organ dysfunction score, PIM pediatric index of 
mortality, CI confidence interval
Variables Mean difference (95 % CI) P value
Vitamin D deficiency 3.50 (0.50–6.53) 0.024
Age 0.007 (−0.01–0.03) 0.51
Gender (male) 0.99 (−1.60–3.59) 0.44
PIM-2 0.006 (−0.05–0.07) 0.84
PELOD 0.05 (−0.14–0.24) 0.61
Diagnosis (infections vs. others) 0.49 (−2.25–3.25) 0.72
Mortality 0.06 (−4.07–3.94) 0.97
Need for mechanical ventilation 1.26 (−1.42–3.95) 0.35
Need for inotropes 3.85 (−2.10–9.89) 0.20
Need for fluid boluses in first 6 h 0.39 (−5.79–5.00) 0.88
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and thus is widely accepted parameter for assessment of 
vitamin D status. The most commonly and widely used 
definition of vitamin D deficiency used to estimate preva-
lence in several populations around the world has been 
a cut off value of 25(OH) D of <20 ng/mL or <50 nmol/L 
and is also recommended by the American Academy of 
Pediatrics (AAP) committee on nutrition [26] and US 
Endocrine Society [15] for starting therapy in sympto-
matic cases. Therefore, we used this definition as has 
been used in similar previous studies in children [3, 4]. 
A level of <37.5  nmol/L or <15  ng/mL indicates severe 
deficiency and may manifest clinically as rickets and/or 
histologically as osteomalacia [18, 27, 28]. The number 
of children with severe deficiency in our study was 62 
(61  %). Severe deficiency like mild-moderate deficiency 
has been shown to be associated with increased disease 
severity, duration of stay as well as mortality in few while 
no association has been found in few other studies [29, 
30, 31]. Most interventional studies have used 20  ng/
mL as the cut off for supplementation [24]. However, it 
appears that the group of patients to benefit the most 
would be the ones with severe deficiency and therefore 
interventional studies should be planned targeting this 
group rather than those with any deficiency.
We anticipated a higher prevalence of vitamin D defi-
ciency in malnourished children due to poor diet, altered 
metabolism or reduced environmental ultraviolet expo-
sure. Although the median 25(OH) D levels were lower 
in the malnourished group, the prevalence of vitamin D 
deficiency was observed to be high in both well-nour-
ished and malnourished groups. Similar observation 
has been documented in the study by Mc Nally et al. [4] 
where the authors observed that, children with higher 
weight for age were more deficient than others. The rea-
sons for this observed phenomenon could be the same as 
described for deficiency in healthy school children such 
as lack of exposure to sunlight due to staying indoors, 
increased skin pigmentation and unknown genetic fac-
tors [7, 9]. The median vitamin D levels were higher in 
the severely malnourished group as one child had a level 
of 54 mmol/L which increased the overall median in this 
population. Vitamin D supplementation at some point in 
time (1 year before enrollment into the study) was prob-
ably responsible for high levels in this child although 
severely undernourished.
Strengths and limitations
Our study emphasizes higher prevalence of vitamin D 
deficiency in critically ill children from a tropical coun-
try and its association with longer duration of ICU stay. 
Well defined eligibility criteria and prospective data col-
lection are the strengths of our study. One major limita-
tion is that we did not include a control group of healthy 
children. But data on this population is already available 
from the Indian sub-continent. The other important limi-
tation is we only had the weight for age Z scores, which 
is not the best method to assess underlying nutritional 
status in children. Low levels of vitamin D are associated 
with inflammatory diseases. Whether they are the cause 
or the effect of vitamin D deficiency is unclear form the 
current evidence [32, 33]. Therefore, there is a need to 
cautiously interpret the results in patients with inflam-
matory conditions.
Conclusions
We observed higher prevalence of vitamin D deficiency 
in critically ill children in our study population and the 
deficiency was associated with increased length of stay in 
the ICU. Our study results could be taken into account 
for designing interventional studies to study the out-
comes of supplementation.
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